New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...